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Sulttu.tnv
With the development of open heart surgery in the last decades the life
expectance and the quality of life of patients with congenital or aquired heart diseases
improved substantially. However, all patients are still at risk for a post perfusion
syndrome (PPS), due to a whole body inflammatory reaction induced by the blood
surface interaction of the extracorporeal circuit. By the blood surface interaction the
contact and complement system are activated. Contact system activation is related
with the impaired hemostasis during and after cardiopulmonary bypass (CPB),
whereas the activ ation of the complement sy stem correlates with the organ dysfunction
following CPB. Although the recent use of protease inhibitors reduced the activation
of the contact system and consequently preserved hemostasis, no reduction of
complement activation nor in organ dysfunction has been observed.
Since complement activation is particularly seen after reperfusion of the heart
and lungs at the completion of the cardiac correction, we considered blood activation
by a process independent of the blood surface interaction. This thesis evaluates the
material independent blood activation during CPB and the role of this activation
process on the development ofthe post perfusion syndrome. We especially investigated
the release of endotoxin, its effect on the whole body inflammatory reaction and the
protective effect of corticosteroids on this reaction.
Chapter l is a general introduction to this thesis, describing and specifying the
targets of the problems. In addenda I,II and III a more detailed description is given
of the post perfusion syndrome, the complement system and endotoxin in relation to
open heart surgery.
To clarify if endotoxin could contribute to the development of the whole body
inflammatory reaction the time relation of release of endotoxin into the systemic
circulation and its activation process during CPB was investigated in a prospective
study on patients undergoing CPB (chapter 2). We found significant increases of
endotoxin concentration after start of bypass and after release of the aortic cross-
clamp, accompagnied by an immediate increase in complement activation (C3a) and
the formation of tumor necrosis factor (TNF) later on. Since TNF is a more potent
mediator of organ dysfunction and endothelial injury than the complement factor
C3a by itself, we concluded that endotoxin may play a pivotal role in the generation
of the whole body inflammatory reaction.
In a placebo controlled double blind study on patients undergoing CPB, the
treatment of dexamethasone on the material irrdependent blood activation and on the
development of the post perfusion syndrome following CPB was investigated
(chapter 3). We showed a strong leukocyte inflammatory reaction upon release of
the aortic cross-clamp of which particulary the TNF formation correlated with the
hemodynamic instabil ity seen in the post operative period. Prophylactic
dexamethasone treatnlent ( I mglkgbw) inhibited the leukocyte inflammatory reaction
of this material independent blood activation effectively and prevented the post
l l l
perfusion phenomena, while no inhibition of complement activation during CPB
was observed. Therefore it could be concluded that the material independent blood
activation, seen after release of the aortic cross-clamp, is the main mediator in the
development of the post perfusion syndrome and not the material dependent
activation induced by the surface of the extracorporeal circuit.
To determine if other corticosteroid regimens could also have an inhibitory
effect on the material independent blood activation process during CPB, we
investigated the effects of three - most frequently used - corticosteroid regimens
during CPB, in a placebo controlled double blind clinical study (chapter 4). A high
dose corticosteroid treatment was the most effective in inhibiting the material
independent activation, especially dexamethasone in a dose of I mg/kgbw, more
than methylprednisolone (30 mg&gbw). A low dose corticosteroid treatment
(prednisolone 1 mg/kgbw) was less effective because of a short duration of action.
None of the corticosteroid regimens had any effect on the material dependent blood
activation.
To determine the effects of endotoxin on the activation of blood cells and
plasmatic systems in more detail and to investigate the protective effects of
corticosteroids on this process, studies were performed in rabbits.
Inchapter5we showedthattheactivationof bloodcells, complement, arachidonic
acid and fibrinolytic systems, seen after a short endotoxin infusion, corresponded
with the activation seen afterrelease of the aortic cross-clamp in patients undergoing
CPB. All rabbits died upon the endotoxin infusion after about 48 hours. This study
showed that endotoxin is indeed a strong activator of blood cells and plasmatic
systems with deleterious effects and therefore can contribute to a whole body
inflammatory reaction.
In chapter 6 we investigated if corticosteroids could prevent the activation
process and deleterious effects of endotoxin in rabbits. The effects of a prophylactic
low and high dose methylprednisolone treatment were evaluated, to determine if a
low dose corticosteroid treatment with less side effects could be as effective as a high
dose. Both corticosteroid treatments were not able to inhibit the complement
activation, but both effectively inhibited the activation of leukocytes, platelets and
their release products and prevented death of all animals. So prophylactic corticosteroid
treatment, both alow andahighdose, prevents thedeleterious effects of endotoxemia
and supports the beneficial effects of corticosteroid treatment on the material
independent activation observed in patients undergoing CPB.
We evaluated in chapter 7 the effect of corticosteroid treatment on complernent
induced white blood cell and platelet aggregation, as is known to occur by
complement activation during CPB. Complement activated plasma and serum were
infused in rabbits, prophylacticaly treated with a high dose methylprednisolone or
a placebo. We showed that high dose methylprednisolone treatment was able to
inhibit in serum the complement induced blood cell aggregation, but not in plasma.































































ment induced blood cell aggregation and that other simultaneously activated
plasmatic components, such as fibrin monomers, play arole in blood cell aggregation.
In an epilogue (chapter 8) the role of the material independent blood activation
on the development of the whole body inflammatory reaction is described. The
release of endotoxin into the systemic circulation, especially by the formation of
TNF, can be responsible for the adverse effects in CPB. Therefore it is important to
focus on the endotoxin release to improve the clinical course following CPB. We
describe the possibilities of preventing systemic endotoxemia and treatment of
endotoxemia in patients undergoing CPB.
CoNcr,usloN
We demonstrated a significant increase in endotoxin concentration during CPB,
causing a material lndependent blood activation with a strong leukocyte inflammatory
reaction. Especially the formation of TNF by endotoxin correlated with the
hemodynamic instabillity seen in the post operative period. Corticosteroid treatment
could inhibitthe leukocyte inflammatory reaction, including theTNFformation, and
so prevented the hemodynamic instability after CPB in a dose dependent way. In the
animal studies we could mimic these effects of endotoxin and the protective effects
of corticosteroid treatment. Furthermore we demonstrated that complement acti-
vation, induced by blood surface interaction, couldnotbe inhibited by corticosteroids.
We therefore postulate that the material independent blood activation is the main
mediator in the development of the post pedusion syndrome instead of the material
dependent blood activation. Therefore attention has to be focussed on the inhibition
and/or prevention of the material independent blood activation during CPB, and
especially on the endotoxin release.
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